ZILRETTA,
ZILRETTA
Raw JSON (click to expand)
{
"_id": "69d4356a3b3830196fa53963",
"safetyreportid": "25946536",
"authoritynumb": null,
"companynumb": "US-ORG100016242-2025000152",
"duplicate": 1,
"fulfillexpeditecriteria": 2,
"occurcountry": "US",
"patient": {
"patientonsetage": 52.0,
"patientonsetageunit": 801,
"patientagegroup": 5,
"patientweight": null,
"patientsex": 2,
"reaction": [
{
"reactionmeddraversionpt": "28.1",
"reactionmeddrapt": "Therapeutic response shortened",
"reactionoutcome": 6
},
{
"reactionmeddraversionpt": "28.1",
"reactionmeddrapt": "Arthralgia",
"reactionoutcome": 3
}
],
"drug": [
{
"drugcharacterization": 1,
"medicinalproduct": "ZILRETTA",
"drugauthorizationnumb": "208845",
"drugbatchnumb": "Unknown",
"drugstructuredosagenumb": null,
"drugstructuredosageunit": null,
"drugseparatedosagenumb": null,
"drugintervaldosageunitnumb": null,
"drugintervaldosagedefinition": null,
"drugcumulativedosagenumb": null,
"drugcumulativedosageunit": null,
"drugdosagetext": "POSSIBLE ONE KNEE",
"drugdosageform": "Suspension for injection",
"drugadministrationroute": "050",
"drugindication": "Product used for unknown indication",
"drugstartdateformat": "602",
"drugstartdate": "2024-01-01T00:00:00",
"drugenddateformat": "602",
"drugenddate": "2024-01-01T00:00:00",
"drugtreatmentduration": null,
"drugtreatmentdurationunit": null,
"drugrecurreadministration": null,
"drugadditional": 4,
"actiondrug": 6,
"activesubstance": {
"activesubstancename": "TRIAMCINOLONE ACETONIDE"
},
"drugrecurrence": []
},
{
"drugcharacterization": 1,
"medicinalproduct": "ZILRETTA",
"drugauthorizationnumb": "208845",
"drugbatchnumb": "Unknown",
"drugstructuredosagenumb": null,
"drugstructuredosageunit": null,
"drugseparatedosagenumb": null,
"drugintervaldosageunitnumb": null,
"drugintervaldosagedefinition": null,
"drugcumulativedosagenumb": null,
"drugcumulativedosageunit": null,
"drugdosagetext": "BOTH KNEES",
"drugdosageform": "Suspension for injection",
"drugadministrationroute": "050",
"drugindication": "Product used for unknown indication",
"drugstartdateformat": "610",
"drugstartdate": "2025-01-01T00:00:00",
"drugenddateformat": "610",
"drugenddate": "2025-01-01T00:00:00",
"drugtreatmentduration": null,
"drugtreatmentdurationunit": null,
"drugrecurreadministration": null,
"drugadditional": 4,
"actiondrug": 6,
"activesubstance": {
"activesubstancename": "TRIAMCINOLONE ACETONIDE"
},
"drugrecurrence": []
}
],
"summary_narrativeincludeclinical": null
},
"primarysource": {
"reportercountry": "US",
"qualification": 5,
"literaturereference": null
},
"primarysourcecountry": "US",
"quarter": "2025Q4",
"receiptdate": "2025-10-22T00:00:00",
"receiptdateformat": "102",
"receivedate": "2025-10-22T00:00:00",
"receivedateformat": "102",
"receiver": {
"receivertype": 6,
"receiverorganization": "FDA"
},
"reportduplicate": [
{
"duplicatesource": "ProPharma (AE)",
"duplicatenumb": "2025-0062218"
},
{
"duplicatesource": "ProPharma (PC)",
"duplicatenumb": "2025-0062219"
},
{
"duplicatesource": "ProPharma (MI)",
"duplicatenumb": "2025-0062190"
}
],
"reporttype": 1,
"safetyreportversion": 1,
"sender": {
"sendertype": 6,
"senderorganization": "PACIRA"
},
"serious": 2,
"seriousnesscongenitalanomali": 2,
"seriousnessdeath": 2,
"seriousnessdisabling": 2,
"seriousnesshospitalization": 2,
"seriousnesslifethreatening": 2,
"seriousnessother": 2,
"source_file": "1_ADR25Q4.xml",
"transmissiondate": "2026-01-19T00:00:00",
"transmissiondateformat": "102"
}